Surgical treatment of neuroblastomas in infants under 12 months of age

Journal of Pediatric Surgery

Volumn 33, Issue 8, 1998, Pages 1246-1250

  Ikeda, Hitoshi ^a   Suzuki, Norio ^b   Takahashi, Atsushi ^b   Kuroiwa, Minoru ^b   Nagashima, Kikuo ^b   Tsuchida, Yoshiaki ^b   Matsuyama, Shiro ^b  

^a Gumna Children S Medical Center   (Japan)

^b NONE

Author keywords

Neuroblastoma; Screening

Indexed keywords

ADRENAL TUMOR; ARTICLE; CANCER SCREENING; CHYLOTHORAX; CHYLOUS ASCITES; CLINICAL ARTICLE; FEMALE; HISTOPATHOLOGY; HORNER SYNDROME; HUMAN; ILEUS; INFANT; KIDNEY FAILURE; MALE; NERVE INJURY; NEUROBLASTOMA; PHRENIC NERVE; PLOIDY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; STATISTICAL ANALYSIS; SURGICAL TECHNIQUE; TUMOR CLASSIFICATION;

EID: 0031948993     PISSN: 00223468     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3468(98)90160-9     Document Type: Article

References (15)

1. Bessho F: Effects of mass screening on age-specific incidence of neuroblastoma. Int J Cancer 67:520-522, 1996
2. Hiraiwa H, Hamazaki M, Takata A, et al: A neuroblastoma cell line derived from a case detected through a mass screening system in Japan. Cancer 79:2036-2044, 1997
3. Yamamoto K, Hanada R, Tanimura M, et al: Natural history of neuroblastoma found by mass screening. Lancet 349:1102, 1997
4. Matsuyama S, Suzuki N, Takahashi A, et al: Mass screening for neuroblastoma in Gunma Prefecture. Jpn J Pediatr Surg 24:27-31, 1992
5. Nagahara N, Ohkawa H, Suzuki H, et al: Staging of neuroblastoma. J Clin Oncol 8:179, 1990
6. Evans AE, D'Angio GJ, Randolph J: A proposed staging for children with neuroblastoma. Cancer 27:374-378, 1971
7. Shimada H, Chatten J, Newton WA, et al: Histopathologic prognostic factors in neuroblastic tumors: Definition of subtypes of ganglioneuroblastoma and an age-linked classification of neuroblastomas. J Natl Cancer Inst 73:405-416, 1984
8. Tsuchida Y, Yokoyama J, Kaneko M, et al: Therapeutic significance of surgery in advanced neuroblastoma: A report from the Study Group of Japan. J Pediatr Surg 27:616-622, 1992
9. Brodeur GM, Pritchard J, Berthold F, et al: Revision of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. J Clin Oncol 11:1466-1477, 1993
10. Kaneko Y, Kanda N, Maseki N, et al: Current urinary mass screening for catecholamine metabolites at 6 months of age may be detecting only a small portion of high-risk neuroblastomas: A chromosome and N-myc amplification study. J Clin Oncol 8:2005-2013, 1990
11. Hachitanda Y, Ishimoto K, Hata J, et al: One hundred neuroblastomas detected through a mass screening system in Japan. Cancer 74:3223-3226, 1994
12. Kusafuka T, Nagahara N, Oue T, et al: Unfavorable DNA ploidy and Ha-ras p21 findings in neuroblastomas detected through mass screening. Cancer 76:695-699, 1995
13. Suita S, Zaizen Y, Yano H, et al: How to deal with advanced cases of neuroblastoma detected by mass screening: A report from the Pediatric Oncology Study Group of the Kyushu Area of Japan. J Pediatr Surg 29:599-603, 1994
14. Woods WG, Tuchman M, Robison LL, et al: A population-based study of the usefulness of screening for neuroblastoma. Lancet 348:1682-1687, 1996
15. Kerbl R, Urban CE: Neuroblastoma mass screening in children. Lancet 349:730, 1997